Time on remedy gathered on study CRFs but only obtainable for clients enrolled under program monitoring eligibility
ific clinicopathological traits nl: no copy quantity alterations, CNN LOH: Copy quantity neutral loss of heterozygosity.(Table three). The ratio of stage I/II tumors was significantly greater in cluster A (90%)…